Kiva's products now reach 80% of the U.S. population. Think about that for a second. It’s a testament to how far the cannabis industry has come and the progress being made. But, as with anything in the cannabis space, there are complexities, caveats, and unique challenges. For instance, in some markets, consumers can access products directly through D2C channels or dispensaries. While these channels can complement each other and drive brand loyalty, the rise of D2C may also create tension with retailers, who were once the sole point of purchase. This week, we sit down with Colin Keeler to break it all down and discuss: Hemp & Cannabis Strategy Minor cannabinoids they are testing Innovations & Consumer Preferences Guest Links https://www.kivaconfections.com/ https://shopkivaconfections.com/ https://x.com/kivaconfections https://www.instagram.com/madebykiva/ Chapters: Introduction and Guest Background (00:00:00) - Bryan Fields introduces Colin Keeler from Kiva, and they discuss Colin's background. Colin shares his journey from investment banking to the cannabis industry, including a brief stint in psychedelic biotech. Kiva's Business Development Strategy (00:02:18) - Colin explains Kiva's approach to expanding into new markets, focusing on their strategy of targeting sizeable markets, working with partners, and being an early mover in different states. Product Innovation and Market Expansion (00:08:14) - The discussion centers on Kiva's product-led approach, highlighting their innovations in edibles like chocolate bars, gummies, and their focus on effects-driven products. Hemp Market Exploration (00:14:31) - Colin discusses Kiva's entry into the hemp market, explaining their cautious approach and how they're navigating the different regulatory landscapes across states. Pricing and Distribution Challenges (00:26:46) - The conversation explores the complexities of pricing in cannabis and hemp markets, including the challenges of maintaining consistent pricing across different states. Innovation and Future Outlook (00:33:09) - Colin talks about Kiva's focus on innovation, particularly around dosage, minor cannabinoids, and creating products that meet consumer wellness needs. Rapid-Fire Questions (00:42:05) - The hosts ask Colin a series of quick, fun questions about his dream smoking session, unique perspectives, and predictions for the edible market. Our Links Bryan Fields on Twitter Kellan Finney on Twitter The Dime on Twitter At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry. 8th Revolution Cannabinoid Playbook is an Industry-leading report covering the entire cannabis supply chain The Dime is a top 5% most shared global podcast The Dime has a New Website. Shhhh its not finished. The Dime is a top 50 Cannabis Podcast Sign up for our playbook here: 🎥 YouTube: The Dime 📸 Instagram: The Dime
Kiva's products now reach 80% of the U.S. population.
Think about that for a second.
It’s a testament to how far the cannabis industry has come and the progress being made.
But, as with anything in the cannabis space, there are complexities, caveats, and unique challenges.
For instance, in some markets, consumers can access products directly through D2C channels or dispensaries. While these channels can complement each other and drive brand loyalty, the rise of D2C may also create tension with retailers, who were once the sole point of purchase.
This week, we sit down with Colin Keeler to break it all down and discuss:
Guest Links
Chapters:
Our Links
At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.
8th Revolution Cannabinoid Playbook is an Industry-leading report covering the entire cannabis supply chain
The Dime is a top 5% most shared global podcast
The Dime has a New Website. Shhhh its not finished.
The Dime is a top 50 Cannabis Podcast
Sign up for our playbook here:
🎥 YouTube: The Dime
📸 Instagram: The Dime